What Is in a Name: from NAFLD to MAFLD and MASLD—Unraveling the Complexities and Implications

被引：0
|
作者：
Mariana M. Ramírez-Mejía
Nahum Méndez-Sánchez
机构：
[1] National Autonomous University of Mexico,Plan of Combined Studies in Medicine (PECEM
[2] Medica Sur Clinic & Foundation,MD/PhD), Faculty of Medicine
[3] National Autonomous University of Mexico,Liver Research Unit
来源：
Current Hepatology Reports | 2023年 / 22卷 / 4期
关键词：
MAFLD; NAFLD; Metabolic syndrome; Metabolic dysfunction; Diabetes; Obesity;
D O I：
10.1007/s11901-023-00620-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：221 / 227
页数：6
相关论文
共 50 条
  • [31] NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver
    De, Arka
    Ahmad, Nishat
    Mehta, Manu
    Singh, Priya
    Duseja, Ajay
    [J]. JOURNAL OF HEPATOLOGY, 2022, 76 (02) : 475 - 477
  • [32] Prognosis of MAFLD vs. NAFLD and implications for a nomenclature change
    Wong, Vincent Wai-Sun
    Lazarus, Jeffrey, V
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 (06) : 1267 - 1270
  • [33] Changing from NAFLD to MASLD: Similar prognosis of unresectable extrahepatic gastrointestinal cancer under chemotherapy between NAFLD and MASLD
    Suzuki, Hiroyuki
    Tanaka, Toshimitsu
    Yamaguchi, Shotaro
    Miwa, Keisuke
    Kawaguchi, Takumi
    [J]. JOURNAL OF HEPATOLOGY, 2024, 80 (04) : e150 - e151
  • [34] From NAFLD to MAFLD: when pathophysiology succeeds
    Tilg, Herbert
    Effenberger, Maria
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (07) : 387 - 388
  • [35] From NAFLD to MAFLD: when pathophysiology succeeds
    Herbert Tilg
    Maria Effenberger
    [J]. Nature Reviews Gastroenterology & Hepatology, 2020, 17 : 387 - 388
  • [36] Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
    Suzuki, Hiroyuki
    Shimose, Shigeo
    Iwamoto, Hideki
    Niizeki, Takashi
    Kawaguchi, Takumi
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (02) : 262 - 265
  • [37] Evolving liver disease insights from NAFLD to MASLD
    Fan, Xiude
    Song, Yongfeng
    Zhao, Jiajun
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2024, 35 (08): : 683 - 686
  • [38] Reply to: "NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver"
    Kim, Donghee
    Ahmed, Aijaz
    [J]. JOURNAL OF HEPATOLOGY, 2022, 76 (02) : 477 - 478
  • [39] From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkiye in terms of metabolic profile and MASLD potential
    Akdas, Sevginur
    Yazihan, Nuray
    [J]. HEPATOLOGY FORUM, 2024, 5 (03):
  • [40] From NAFLD to MASLD: Promise and pitfalls of a new definition
    Cusi, Kenneth
    Younossi, Zobair
    Roden, Michael
    [J]. HEPATOLOGY, 2024, 79 (02) : E13 - E15
12345